Alternative clinical trial designs

被引:4
|
作者
Harvin, John A. [1 ]
Zarzaur, Ben L. [2 ]
Nirula, Raminder [3 ]
King, Benjamin T. [4 ]
Malhotra, Ajai K. [5 ]
机构
[1] Univ Texas Houston, McGovern Med Sch, Surg, Houston, TX USA
[2] Univ Wisconsin, Sch Med & Publ Hlth, Surg, Madison, WI USA
[3] Univ Utah, Sch Med, Surg, Salt Lake City, UT USA
[4] Univ Texas Austin, Dell Med Sch, Neurol, Austin, TX 78712 USA
[5] Univ Vermont, Med Ctr, Surg, Burlington, VT 05401 USA
关键词
SPLENIC INJURY; TRAUMA; PLASMA; EMBOLIZATION; MULTICENTER; MANAGEMENT; RATIONALE; MORTALITY;
D O I
10.1136/tsaco-2019-000420
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
High-quality clinical trials are needed to advance the care of injured patients. Traditional randomized clinical trials in trauma have challenges in generating new knowledge due to many issues, including logistical difficulties performing individual randomization, unclear pretrial estimates of treatment effect leading to often unpowered studies, and difficulty assessing the generalizability of an intervention given the heterogeneity of both patients and trauma centers. In this review, we discuss alternative clinical trial designs that can address some of these difficulties. These include pragmatic trials, cluster randomization, cluster randomized stepped wedge designs, factorial trials, and adaptive designs. Additionally, we discuss how Bayesian methods of inference may provide more knowledge to trauma and acute care surgeons compared with traditional, frequentist methods.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] International Symposium on Adaptive Clinical Trial Designs
    Christian Gluud
    Anders Dejgaard
    Michael Krams
    Ingrid Wallenbeck
    Gervais Tougas
    Jorn Wetterslev
    Carl-Fredrik Burman
    Per Spindler
    Drug information journal : DIJ / Drug Information Association, 2008, 42 : 93 - 97
  • [42] International symposium on adaptive clinical trial designs
    Gluud, Christian
    Dejgaard, Anders
    Krams, Michael
    Wallenbeck, Ingrid
    Tougas, Gervais
    Wetterslev, Jorn
    Borman, Carl-Fredrik
    Spindler, Per
    DRUG INFORMATION JOURNAL, 2008, 42 (01): : 93 - 97
  • [43] ALTERNATIVE TRIAL DESIGNS USED IN ONCOLOGY PHASE I CLINICAL TRIALS: A LITERATURE SURVEY (2008-2011).
    Rajan, S.
    Budha, N.
    Dresser, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S53 - S53
  • [44] Patients Driving the Clinical Trial Designs - Democracy in Clinical Research
    Bhardwaj, Payal
    Kumar, Jeba
    Yadav, Raj Kumar
    REVIEWS ON RECENT CLINICAL TRIALS, 2019, 14 (04) : 237 - 246
  • [45] Clinical Trial Designs to Support Clinical Utility of Pharmacogenomic Testing
    Drozda, Katarzyna
    Pacanowski, Michael A.
    PHARMACOTHERAPY, 2017, 37 (09): : 1000 - 1004
  • [46] Adaptation in clinical development plans and adaptive clinical trial designs
    Lai, Tze Leung
    Liao, Olivia Yueh-Wen
    Zhu, Ray Guangrui
    STATISTICS AND ITS INTERFACE, 2012, 5 (04) : 431 - 442
  • [47] Creating clinical trial designs that incorporate clinical outcome assessments
    Gilbert, Mark R.
    Rubinstein, Lawrence
    Lesser, Glenn
    NEURO-ONCOLOGY, 2016, 18 : 21 - 25
  • [48] Alternative designs
    Acta Polytechnica Scandinavica, Mathematics and Computer Science Series, 1993, (60):
  • [49] Ethics of alternative trial designs and methods in low-resource settings
    Rieke van der Graaf
    Phaik Yeong Cheah
    Trials, 20
  • [50] Ethics of alternative trial designs and methods in low-resource settings
    van der Graaf, Rieke
    Cheah, Phaik Yeong
    TRIALS, 2019, 20 (01)